Roche, PTC & SMA Foundation Agreement to Develop a Treatment for SMA Receives Extensive Coverage

On November 29, 2011, Roche, PTC Therapeutics and the SMA Foundation announced the signing of an agreement to develop a treatment for Spinal Muscular Atrophy. Several media sources reported on the agreement including BioCentury, BioWorld Today, Bloomberg Businessweek, Chemical & Engineering News, Clinical Professionals, Dow Jones VentureWire, Drug Discovery News, FierceBiotech, Genetic Engineering and Biology News, InPharm, MEDCITY Investing, NJBIZ, Pharma Times,  PMLiVE Intelligence Online, QUEST – MDA’s Research and Health Magazine, RTT News, SCRIP, The Pharma Letter, The Pink Sheet Daily, and Xconomy.